CIPLA

What Cipla promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 15 tracked 3 delivered 1 missed 11 open
  • Product Supply delayed said Q3 FY26 Promised: resume in H1 FY'27 Q1 FY27: Management states the timing is 'a little bit fluid' and dependent on regulatory approvals, confirming the delay beyond FY27. No contribution is included in projections.
  • Product Launch on track said Q4 FY25 Promised: 2 to 3 peptide assets in FY '26 Q1 FY27: Management confirmed 'one peptide, which is large' is among the key upcoming launches for FY27, keeping the delayed promise on track.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 15 tracked commitments for Cipla — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens